These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7642256)

  • 1. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.
    Hopkins S; Kraehenbuhl JP; Schödel F; Potts A; Peterson D; de Grandi P; Nardelli-Haefliger D
    Infect Immun; 1995 Sep; 63(9):3279-86. PubMed ID: 7642256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R
    Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization with recombinant Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin: effect of boosting on mucosal, systemic and immunoglobulin G subclass response.
    Kohler JJ; Pathangey LB; Brown TA
    Oral Microbiol Immunol; 1998 Apr; 13(2):81-8. PubMed ID: 9573798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits.
    Corthésy-Theulaz IE; Hopkins S; Bachmann D; Saldinger PF; Porta N; Haas R; Zheng-Xin Y; Meyer T; Bouzourène H; Blum AL; Kraehenbuhl JP
    Infect Immun; 1998 Feb; 66(2):581-6. PubMed ID: 9453612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.
    Nardelli-Haefliger D; Roden RB; Benyacoub J; Sahli R; Kraehenbuhl JP; Schiller JT; Lachat P; Potts A; De Grandi P
    Infect Immun; 1997 Aug; 65(8):3328-36. PubMed ID: 9234794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
    Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
    Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium.
    Allen JS; Dougan G; Strugnell RA
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):275-81. PubMed ID: 10727882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
    Tacket CO; Kelly SM; Schödel F; Losonsky G; Nataro JP; Edelman R; Levine MM; Curtiss R
    Infect Immun; 1997 Aug; 65(8):3381-5. PubMed ID: 9234801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus.
    Stabel TJ; Mayfield JE; Tabatabai LB; Wannemuehler MJ
    Infect Immun; 1990 Jul; 58(7):2048-55. PubMed ID: 2114357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.
    Karem KL; Chatfield S; Kuklin N; Rouse BT
    Infect Immun; 1995 Dec; 63(12):4557-63. PubMed ID: 7591105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.
    Roberts M; Bacon A; Li J; Chatfield S
    Infect Immun; 1999 Aug; 67(8):3810-5. PubMed ID: 10417142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and mucosal intestinal antibody response of sheep immunized with aromatic-dependent live or killed Salmonella typhimurium.
    Mukkur TK; Walker KH; Baker P; Jones D
    Comp Immunol Microbiol Infect Dis; 1995 Jan; 18(1):27-39. PubMed ID: 7889730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.
    Redman TK; Harmon CC; Michalek SM
    Infect Immun; 1994 Aug; 62(8):3162-71. PubMed ID: 8039885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
    Price GA; Russell MW; Cornelissen CN
    Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.
    Hordnes K; Digranes A; Haugen IL; Helland DE; Ulstein M; Jonsson R; Haneberg B
    J Reprod Immunol; 1995 Mar; 28(3):247-62. PubMed ID: 7473434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.